Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
Overview
Authors
Affiliations
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in children generally have milder presentations, but severe disease can occur in all ages. MIS-C and persistent post-acute COVID-19 symptoms can be experienced by children with previous infection and emphasize the need for infection prevention. Optimal treatment for COVID-19 is not known, and clinical trials should include children to guide therapy. Vaccines are the best tool at preventing infection and severe outcomes of COVID-19. Children suffered disproportionately during the pandemic not only from SARS-CoV-2 infection but because of disruptions to daily life, access to primary care, and worsening income inequalities.
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study.
Arian Y, Faranoush P, Ehsanipour F, Sadighnia N, Elahinia A, Faranoush M Int J Hematol Oncol Stem Cell Res. 2024; 18(4):313-322.
PMID: 39703466 PMC: 11652701. DOI: 10.18502/ijhoscr.v18i4.16756.
Rao S, Jing N, Liu X, Lorman V, Maltenfort M, Schuchard J Sci Rep. 2023; 13(1):21005.
PMID: 38017007 PMC: 10684592. DOI: 10.1038/s41598-023-47655-y.
Effect of the COVID-19 pandemic on the pediatric infectious disease landscape.
Shmueli M, Lendner I, Ben-Shimol S Eur J Pediatr. 2023; 183(3):1001-1009.
PMID: 37726566 DOI: 10.1007/s00431-023-05210-x.
Acceptability and Feasibility of Saliva-delivered PCR Coronavirus 2019 Tests for Young Children.
Lee R, Todd M, Oh H, Han S, Santana M, Aguilar-Troncoso J Pediatrics. 2023; 152(Suppl 1).
PMID: 37394507 PMC: 10312283. DOI: 10.1542/peds.2022-060352D.
Editorial: COVID-19 and hyper inflammation syndrome: Different presentation and management.
Poddighe D, Ziaee V, Kasapcopur O Front Pediatr. 2022; 10:1022701.
PMID: 36160806 PMC: 9501999. DOI: 10.3389/fped.2022.1022701.